Meta-Analysis of Suicide-Related Behavior Events in Patients Treated With Atomoxetine

Meta-analysis in clinical trials

DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · see citing works

Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial Reliability and Validity Data

KAUFMAN, J., BIRMAHER, B., BRENT, D., RAO, U., FLYNN, C., MORECI, P., WILLIAMSON, D., & RYAN, N. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199707000-00021 · Cited by 10,148 · see citing works

Attention-deficit/hyperactivity disorder: a selective overview.

Biederman, J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.020 · Cited by 1,439 · see citing works

Attention-deficit hyperactivity disorder : a clinical workbook

Barkley, R. A., & Murphy, K. R. (1991) · Cited by 1,144 · see citing works

Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder

Bymaster, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00346-9 · Cited by 1,123 · see citing works

Suicidality in Pediatric Patients Treated With Antidepressant Drugs

Hammad, T. A., Laughren, T., & Racoosin, J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.332 · Cited by 1,054 · see citing works

Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA’s pediatric suicidal risk analysis of antidepressants

Posner, K., Oquendo, M. A., Gould, M., Stanley, B., & Davies, M. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.7.1035 · Cited by 1,025 · see citing works

Risk Factors for Adolescent Suicide

Brent, D. A., Perper, J. A., Goldstein, C. E., Kolko, D. J., Allan, M. J., Allman, C. J., & Zelenak, J. P. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800300079011 · Cited by 892 · see citing works

Estimation of a Common Effect Parameter from Sparse Follow-Up Data

Greenland, S., & Robins, J. M. (1985) · Biometrics · doi:10.2307/2530643 · Cited by 798 · see citing works

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies

Michelson, D., Adler, L., Spencer, T., Reimherr, F. W., West, S. A., Allen, A. J., Kelsey, D., Wernicke, J., Dietrich, A., & Milton, D. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01671-2 · Cited by 790 · see citing works

Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Dose-Response Study

Michelson, D., Faries, D., Wernicke, J., Kelsey, D., Kendrick, K., Sallee, F. R., Spencer, T., & the Atomoxetine ADHD Study Group (2001) · Pediatrics · doi:10.1542/peds.108.5.e83 · Cited by 666 · see citing works

Once-Daily Atomoxetine Treatment for Children and Adolescents With Attention Deficit Hyperactivity Disorder: A Randomized, Placebo-Controlled Study

Michelson, D., Allen, A. J., Busner, J., Casat, C., Dunn, D., Kratochvil, C., Newcorn, J., Sallee, F. R., Sangal, R. B., Saylor, K., et al. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1896 · Cited by 599 · see citing works

Child and Adolescent Psychiatry : A Comprehensive Textbook

Lewis, M. (2002) · Cited by 528 · see citing works

Once-Daily Atomoxetine Treatment for Children With Attention-Deficit/Hyperactivity Disorder, Including an Assessment of Evening and Morning Behavior: A Double-Blind, Placebo-Controlled Trial

Kelsey, D. K., Sumner, C. R., Casat, C. D., Coury, D. L., Quintana, H., Saylor, K. E., Sutton, V. K., Gonzales, J., Malcolm, S. K., Schuh, K. J., et al. (2004) · Pediatrics · doi:10.1542/peds.114.1.e1 · Cited by 464 · see citing works

Psychosocial Health Among Young Victims and Offenders of Direct and Indirect Bullying

van der Wal, M. F., de Wit, C. A. M., & Hirasing, R. A. (2003) · PEDIATRICS · doi:10.1542/peds.111.6.1312 · Cited by 462 · see citing works

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Suicidal Behavior

Shaffer, D., & Pfeffer, C. R. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200107001-00003 · Cited by 460 · see citing works

Family food insufficiency, but not low family income, is positively associated with dysthymia and suicide symptoms in adolescents

Alaimo, K., Olson, C. M., & Frongillo, E. A. (2002) · The Journal of Nutrition · doi:10.1093/jn/132.4.719 · Cited by 410 · see citing works

Results From 2 Proof-of-Concept, Placebo-Controlled Studies of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder

Spencer, T., Heiligenstein, J. H., Biederman, J., Faries, D. E., Kratochvil, C. J., Conners, C. K., & Potter, W. Z. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1209 · Cited by 333 · see citing works

Multimodal Treatment of ADHD in the MTA: An Alternative Outcome Analysis

Conners, C. K., Epstein, J. N., March, J. S., Angold, A. C., Wells, K. C., Klaric, J., Swanson, J. M., Arnold, L. E., Abikoff, H., Elliott, G. R., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00010 · Cited by 285 · see citing works

Comorbidity of mental disorders in the post-mortem diagnosis of completed suicide in children and adolescents

Shafii, M. B., Steltz-Lenarsky, J., Derrick, A., Beckner, C., & Whittinghill, J. R. (1988) · Journal of Affective Disorders · doi:10.1016/0165-0327(88)90020-1 · Cited by 231 · see citing works

Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders

Allen, A. J., Kurlan, R. M., Gilbert, D. L., Coffey, B. J., Linder, S. L., Lewis, D. W., Winner, P. K., Dunn, D. W., Dure, L. S., Sallee, F. R., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000188869.58300.a7 · Cited by 225 · see citing works

Attention deficit hyperactivity disorder and suicide: a review of possible associations

James, A., Lai, F. H., & Dahl, C. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00384.x · Cited by 224 · see citing works

Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat

Swanson, C. J., Perry, K. W., Koch-Krueger, S., Katner, J., Svensson, K. A., & Bymaster, F. P. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.11.022 · Cited by 214 · see citing works

Suicide Attempts and Suicidal Ideation in a Birth Cohort of 16-Year-Old New Zealanders

Fergusson, D. M., & Lynskey, M. T. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199510000-00016 · Cited by 193 · see citing works

Current concepts on the neurobiology of Attention-Deficit/Hyperactivity Disorder

Biederman, J., & Faraone, S. V. (2002) · Journal of Attention Disorders · doi:10.1177/070674370200601s03 · Cited by 192 · see citing works

Antidepressant Treatment and Risk of Suicide Attempt by Adolescents with Major Depressive Disorder: A Propensity-Adjusted Retrospective Cohort Study

Valuck, R. J., Libby, A. M., Sills, M. R., Giese, A. A., & Allen, R. R. (2004) · CNS Drugs · doi:10.2165/00023210-200418150-00006 · Cited by 182 · see citing works

Suicide in young people aged 15–24: a psychological autopsy study

Houston, K., Hawton, K., & Shepperd, R. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00175-0 · Cited by 177 · see citing works

Treatment of depression in children and adolescents

Ryan, N. D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67321-7 · Cited by 176 · see citing works

Psychiatric Comorbidity Associated With DSM-IV ADHD in a Nonreferred Sample of Twins

WILLCUTT, E. G., PENNINGTON, B. F., CHHABILDAS, N. A., FRIEDMAN, M. C., & ALEXANDER, J. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199911000-00009 · Cited by 173 · see citing works

Suicidality and correlates among rural adolescents of China

Liu, X., Tein, J., Zhao, Z., & Sandler, I. N. (2005) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2004.08.027 · Cited by 161 · see citing works

CYP2D6 and Clinical Response to Atomoxetine in Children and Adolescents With ADHD

MICHELSON, D., READ, H. A., RUFF, D. D., WITCHER, J., ZHANG, S., & McCRACKEN, J. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000246056.83791.b6 · Cited by 159 · see citing works

A Randomized, Placebo-Controlled Study of Once-Daily Atomoxetine in the School Setting in Children With ADHD

Weiss, M., Tannock, R., Kratochvil, C., Dunn, D., Velez-Borras, J., Thomason, C., Tamura, R., Kelsey, D., Stevens, L., & Allen, A. J. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000163280.47221.c9 · Cited by 147 · see citing works

Suicide in Adolescents With Disruptive Disorders

Renaud, J., Brent, D. A., Birmaher, B. B., Chiappetta, L., & Bridge, J. A. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199907000-00014 · Cited by 109 · see citing works

The Flawed Basis for FDA Post-Marketing Safety Decisions: The Example of Anti-Depressants and Children

Klein, D. F. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300996 · Cited by 94 · see citing works

Atomoxetine: a selective noradrenaline reuptake inhibitor for the treatment of attention-deficit/hyperactivity disorder

Kratochvil, C. J., Vaughan, B. S., Harrington, M. J., & Burke, W. J. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.7.1165 · Cited by 94 · see citing works

Suicidal Ideation Among 8-Year-Olds Who Are Maltreated and At Risk: Findings From the LONGSCAN Studies

Thompson, R., Briggs, E. C., English, D. J., Dubowitz, H., Lee, L.-C., Brody, K., Everson, M. D., & Hunter, W. M. (2004) · Child Maltreatment · doi:10.1177/1077559504271271 · Cited by 90 · see citing works

Suicidal behavior in the family and adolescent risk behavior

Cerel, J., & Roberts, T. A. (2005) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2004.08.010 · Cited by 90 · see citing works

Assessment and treatment of attention deficit hyperactivity disorder in children with comorbid psychiatric illness

Waxmonsky, J. G. (2003) · Current Opinion in Pediatrics · doi:10.1097/00008480-200310000-00006 · Cited by 89 · see citing works

Factors in the Assessment of Suicidality in Youth

Posner, K., Melvin, G. A., Stanley, B., Oquendo, M. A., & Gould, M. S. (2007) · CNS Spectrums · doi:10.1017/s1092852900020678 · Cited by 86 · see citing works

Suicidal Risk in Antidepressant Drug Trials

Baldessarini, R. J., Pompili, M., & Tondo, L. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.246 · Cited by 80 · see citing works

Review of Safety Assessment Methods Used in Pediatric Psychopharmacology

Greenhill, L. L., Shockey, E. M., Davies, M., Fisher, P. W., Fried, J. E., Capasso, L., ROSENGARTEN, J., Vitiello, B., Riddle, M. A., VARIPATIS, E., et al. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000046841.56865.37 · Cited by 77 · see citing works

How Can We Improve the Assessment of Safety in Child and Adolescent Psychopharmacology?

Vitiello, B., Riddle, M. A., Walkup, J. T., Labellarte, M. J., VARIPATIS, E., Greenhill, L. L., Davies, M., Capasso, L., March, J. S., Levine, J., et al. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000046840.90931.36 · Cited by 55 · see citing works

Seizures and Prolonged QTc With Atomoxetine Overdose

Sawant, S., & DAVISS, S. R. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.4.757 · Cited by 54 · see citing works

Challenging times: a study to detect Irish adolescents at risk of psychiatric disorders and suicidal ideation

Lynch, F., Mills, C., Daly, I., & Fitzpatrick, C. (2004) · Journal of Adolescence · doi:10.1016/j.adolescence.2004.01.001 · Cited by 45 · see citing works

Suicidal ideation and suicide attempts among child and adolescent psychiatric inpatients in Finland

Haavisto, A. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00093-9 · Cited by 39 · see citing works

Asthma and Suicidal Ideation Among Youth in the Community

Goodwin, R. D., & Marušič†, A. (2004) · Crisis · doi:10.1027/0227-5910.25.3.99 · Cited by 39 · see citing works

Interviewing Prepubertal Children about Suicidal Ideation and Behavior

Jacobsen, L. K., Rabinowitz, I., Popper, M. S., et al. (1994) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199405000-00001 · Cited by 35 · see citing works

On the variance estimator for the Mantel-Haenszel risk difference

Sato, T. S. (1989) · Biometrics · Cited by 35 · see citing works

Isolated atomoxetine overdose resulting in seizure

Kashani, J., & Ruha, A. (2007) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2006.05.048 · Cited by 33 · see citing works

Psychological and Family Factors Associated with Suicidal Ideation in Pre-Adolescents

Viñas, F., Canals, J., Pérez, M. E. G., et al. (2002) · The Spanish Journal of Psychology · doi:10.1017/s1138741600005795 · Cited by 31 · see citing works

Suicidal ideation and acts of self-harm among Dublin school children

O’Sullivan, M. J., & Fitzgerald, M. (1998) · Journal of Adolescence · doi:10.1006/jado.1998.0163 · Cited by 30 · see citing works

Depression and Suicidal Ideation Among Mexican American School-Aged Children

Cowell, J. M., Gross, D. A., McNaughton, D. B., Ailey, S. H., & Fogg, L. (2005) · Research and theory for nursing practice · doi:10.1891/rtnp.19.1.77.66337 · Cited by 26 · see citing works

Aggressive behaviors in early adolescence and subsequent suicidality among urban youths

O’Donnell, L. N., Stueve, A., & Wilson‐Simmons, R. (2005) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2004.11.135 · Cited by 25 · see citing works

Atomoxetine Ingestions in Children: A Report from Poison Centers

Spiller, H. A., Lintner, C. P., & Winter, M. L. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e646 · Cited by 24 · see citing works

Wirksamkeit von Atomoxetin bei Kindern, Jugendlichen und Erwachsenen mit ADHS

Sevecke, K., Battel, S., Dittmann, R., Lehmkuhl, G., & Döpfner, M. (2005) · Der Nervenarzt · doi:10.1007/s00115-005-1970-1 · Cited by 19 · see citing works

Children and Adolescent Exposures to Atomoxetine Hydrochloride Reported to a Poison Control Center

Stojanovski, S. D., Robinson, R. F., Baker, D., Casavant, M. J., Hayes, J. R., & Nahata, M. C. (2006) · Clinical Toxicology · doi:10.1080/15563650600584311 · Cited by 16 · see citing works

Data Safety Monitoring Boards and Other Study Methodologies That Address Subject Safety in “High-Risk” Therapeutic Trials in Youths

Carandang, C. G., Santor, D. A., Gardner, D. M., CARREY, N. J., & Kutcher, S. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31802f5f54 · Cited by 10 · see citing works

Increased risk of self-injury and suicide for patients with attention-deficit/hyperactivity disorder

Swensen, A. R., Allen, A. J., Kruesi, M. J. P., et al. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)80729-5 · Cited by 8 · see citing works

ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

Subcommittee on Attention-Deficit/Hyperactivity Disorder, S. C. O. Q. I. A. M. (2011) · Pediatrics · doi:10.1542/peds.2011-2654 · Cited by 2,185 · see citing works

Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

Wolraich, M. L., Hagan, J. F., Allan, C., Chan, E., Davison, D., Earls, M., Evans, S. W., Flinn, S. K., Froehlich, T., Frost, J., et al. (2019) · Pediatrics · doi:10.1542/peds.2019-2528 · Cited by 1,410 · see citing works

Atomoxetine: A Review of its Use in Attention-Deficit Hyperactivity Disorder in Children and Adolescents

Garnock-Jones, K. P., & Keating, G. M. (2009) · Pediatric Drugs · doi:10.2165/00148581-200911030-00005 · Cited by 392 · see citing works

European guidelines on managing adverse effects of medication for ADHD

(for the European Guidelines Group), Graham, J., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Dittmann, R. W., Döpfner, M., Hamilton, R., Hollis, C., et al. (2011) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-010-0140-6 · Cited by 374 · see citing works

Practitioner Review: Current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents

Cortese, S., Holtmann, M., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Dittmann, R. W., Graham, J., Taylor, E., Sergeant, J., et al. (2013) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12036 · Cited by 336 · see citing works

Drug treatment for attention-deficit/hyperactivity disorder and suicidal behaviour: register based study

Chen, Q., Sjolander, A., Runeson, B., D'Onofrio, B. M., Lichtenstein, P., & Larsson, H. (2014) · BMJ · doi:10.1136/bmj.g3769 · Cited by 170 · see citing works

Efficacy and safety of atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: results from a comprehensive meta-analysis and metaregression

Schwartz, S., & Correll, C. U. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.11.005 · Cited by 166 · see citing works

Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis

Hanwella, R., Senanayake, M., & de Silva, V. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-176 · Cited by 137 · see citing works

Common Etiological Factors of Attention-Deficit/Hyperactivity Disorder and Suicidal Behavior: A Population-Based Study in Sweden

Ljung, T., Chen, Q., Lichtenstein, P., & Larsson, H. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.363 · Cited by 132 · see citing works

To stop or not to stop? How long should medication treatment of attention-deficit hyperactivity disorder be extended?

van de Loo-Neus, G. H. H., Rommelse, N., & Buitelaar, J. K. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.03.008 · Cited by 98 · see citing works

A review of the adverse effects and safety of noradrenergic antidepressants

Whiskey, E., & Taylor, D. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113492027 · Cited by 64 · see citing works

Atomoxetine as an Adjunct Therapy in the Treatment of Co-Morbid Attention-Deficit/Hyperactivity Disorder in Children and Adolescents with Bipolar I or II Disorder

Chang, K., Nayar, D., Howe, M., & Rana, M. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2009.0030 · Cited by 56 · see citing works

Viloxazine in the Management of CNS Disorders: A Historical Overview and Current Status

Findling, R. L., Candler, S. A., Nasser, A. F., Schwabe, S., Yu, C., Garcia-Olivares, J., O’Neal, W., & Newcorn, J. H. (2021) · CNS Drugs · doi:10.1007/s40263-021-00825-w · Cited by 55 · see citing works

Atomoxetine for Treating ADHD Symptoms in Autism: A Systematic Review

Ghanizadeh, A. (2013) · Journal of Attention Disorders · doi:10.1177/1087054712443154 · Cited by 43 · see citing works

Toward Quality Care in ADHD: Defining the Goals of Treatment

Rostain, A., Jensen, P. S., Connor, D. F., Miesle, L. M., & Faraone, S. V. (2015) · Journal of Attention Disorders · doi:10.1177/1087054712473835 · Cited by 33 · see citing works

Spotlight on Atomoxetine in Attention-Deficit Hyperactivity Disorder in Children and Adolescents†

Garnock-Jones, K. P., & Keating, G. M. (2010) · CNS Drugs · doi:10.2165/11203670-000000000-00000 · Cited by 32 · see citing works

Psychopharmacological treatment of ADHD symptoms in children with autism spectrum disorder

Handen, B. L., Taylor, J., & Tumuluru, R. (2011) · ijamh · doi:10.1515/ijamh.2011.039 · Cited by 26 · see citing works

Differential impact of methylphenidate and atomoxetine on sustained attention in youth with attention‐deficit/hyperactivity disorder

Bedard, A., Stein, M. A., Halperin, J. M., Krone, B., Rajwan, E., & Newcorn, J. H. (2014) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12272 · Cited by 62 · see citing works

A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit/hyperactivity disorder

Carlson, G. A., Dunn, D., Kelsey, D. K., Ruff, D. D., Ball, S. G., Ahrbecker, L. M., & Allen, A. J. (2007) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/1753-2000-1-10 · Cited by 44 · see citing works

Atomoxetine Versus Stimulants for Treatment of Attention Deficit/Hyperactivity Disorder

Gibson, A. P., Bettinger, T. L., Patel, N. C., & Crismon, M. L. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g582 · Cited by 86 · see citing works

The Efficacy of Atomoxetine for the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Comprehensive Review of Over a Decade of Clinical Research

Savill, N. C., Buitelaar, J. K., Anand, E., Day, K. A., Treuer, T., Upadhyaya, H. P., & Coghill, D. (2015) · CNS Drugs · doi:10.1007/s40263-014-0224-9 · Cited by 57 · see citing works

Atomoxetine could improve intra-individual variability in drug-naïve adults with attention-deficit/hyperactivity disorder comparably with methylphenidate: A head-to-head randomized clinical trial

Ni, H., Gu, S.-L. H., Lin, H., Lin, Y., Yang, L.-K., Huang, H., & Gau, S. S. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116632377 · Cited by 21 · see citing works